Retinal vein occlusion (RVO) is the most common retinal vascular disease after diabetic
retinopathy. Owing to its multifactorial nature, however, management of this condition …

Venous thromboembolism (VTE) is a serious and often fatal medical condition with an
increasing incidence. The treatment of VTE is undergoing tremendous changes with the …

The article offers information on the guidelines for investigating and managing the venous
thrombosis at unusual sites. It mentions that deep vein thrombosis (DVT) of the lower limb …

Intravitreal pharmacotherapy has revolutionized our treatment of retinal vascular diseases,
including RVO. Although these intravitreal agents are effective, our understanding of their …

Purpose To evaluate the feasibility of robot‐assisted retinal vein cannulation for retinal vein
occlusion. Methods Prospective experimental study performed in in vivo porcine eyes. A …

Background: The availability of new therapeutic approaches, particularly intravitreal anti-
vascular endothelial growth factor (anti-VEGF) therapies, has prompted significant changes …

Retinal vein occlusion (RVO) is a disease that is often associated with a variety of systemic
disorders including arterial hypertension, diabetes mellitus, dyslipidemia and systemic …

Abstract In 1855, Liebreich [1] first described the clinical picture of retinal vein occlusion and
called it “retinal apoplexy.” Michel [2] established it as a clinical entity resulting from …

Optimal management of retinal vein occlusion (RVO) is still a matter of debate.
Antithrombotic and fibrinolytic drugs have been investigated after demonstration of a role of …

Aims Retinal vein occlusion (RVO) is the most frequent retinal vascular disease after
diabetic retinopathy in which arterial risk factors are much more relevant than venous …